Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $321,507 | 24 | 82.5% |
| Consulting Fee | $29,843 | 18 | 7.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,700 | 10 | 4.8% |
| Honoraria | $10,526 | 5 | 2.7% |
| Food and Beverage | $8,933 | 223 | 2.3% |
| Travel and Lodging | $245.70 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $363,540 | 109 | $0 (2023) |
| LENSAR, Inc. | $13,158 | 33 | $0 (2024) |
| OCULUS, Inc. | $3,000 | 3 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $2,657 | 16 | $0 (2024) |
| Ziemer USA | $2,500 | 1 | $0 (2018) |
| Omeros Corporation | $1,708 | 16 | $0 (2021) |
| Carl Zeiss Meditec, Inc. | $801.91 | 9 | $0 (2023) |
| Allergan, Inc. | $300.42 | 16 | $0 (2022) |
| BIOTISSUE HOLDINGS INC. | $253.04 | 8 | $0 (2024) |
| Glaukos Corporation | $246.62 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $951.69 | 25 | Bausch & Lomb Americas Inc. ($384.66) |
| 2023 | $2,945 | 19 | Bausch & Lomb Americas Inc. ($2,249) |
| 2022 | $2,422 | 29 | Johnson & Johnson Surgical Vision, Inc. ($1,602) |
| 2021 | $5,597 | 19 | Johnson & Johnson Surgical Vision, Inc. ($5,082) |
| 2020 | $10,653 | 28 | Johnson & Johnson Surgical Vision, Inc. ($10,007) |
| 2019 | $8,305 | 41 | Johnson & Johnson Surgical Vision, Inc. ($6,186) |
| 2018 | $246,053 | 56 | Johnson & Johnson Surgical Vision, Inc. ($232,128) |
| 2017 | $112,828 | 64 | Johnson & Johnson Surgical Vision, Inc. ($108,222) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| 11/15/2024 | Bausch & Lomb Americas Inc. | ENVISTA ENVY (Device) | Food and Beverage | In-kind items and services | $80.01 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: EYE CARE | ||||||
| 11/04/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $17.51 | General |
| 10/23/2024 | Bausch & Lomb Americas Inc. | ENVISTA ASPIRE TORIC (Device) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Ophthalmology | ||||||
| 09/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 08/19/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $23.65 | General |
| 08/13/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $69.74 | General |
| Category: Glaucoma | ||||||
| 07/17/2024 | Bausch & Lomb Americas Inc. | SOFPORT AO (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Ophthalmology | ||||||
| 07/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $42.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: EYE CARE | ||||||
| 06/20/2024 | Bausch & Lomb Americas Inc. | SOFPORT AO (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Bausch & Lomb Americas Inc. | SOFPORT AO (Device) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Ophthalmology | ||||||
| 05/27/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $21.41 | General |
| 04/24/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| 04/16/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Ophthalmology | ||||||
| 04/01/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 02/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: EYE CARE | ||||||
| 02/07/2024 | Alcon Vision LLC | Wavelight Refractive Suite (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Ophthalmology | ||||||
| 02/04/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $174.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/04/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $78.28 | General |
| 01/02/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Ophthalmology | ||||||
| 01/02/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Ophthalmology | ||||||
| 01/02/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SUR-CAT-652-01 | Johnson & Johnson Surgical Vision, Inc. | $172,165 | 7 |
| TECNIS Next Generation Intraocular Lenses | Johnson & Johnson Surgical Vision, Inc. | $72,992 | 5 |
| TIOL-207-STEP | Johnson & Johnson Surgical Vision, Inc. | $29,000 | 2 |
| Clinical Investigation of the TECNIS Symfony Extended Range of Vision IOL Model ZXR00 | Johnson & Johnson Surgical Vision, Inc. | $21,600 | 1 |
| Clinical Investigation of the Bacterially Derived Healon5 Ophthalmic Viscosurgical Device OVD | Johnson & Johnson Surgical Vision, Inc. | $19,700 | 4 |
| Post Approval Study of the TECNIS Toric IOL Models ZCT300 and ZCT400 | Johnson & Johnson Surgical Vision, Inc. | $4,000 | 1 |
| TIOL-202-TPAS | Johnson & Johnson Surgical Vision, Inc. | $1,500 | 2 |
| EDOF-121-NGPC | Johnson & Johnson Surgical Vision, Inc. | $550.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,362 | 3,404 | $3.1M | $530,050 |
| 2022 | 17 | 2,526 | 3,526 | $3.0M | $532,633 |
| 2021 | 17 | 2,635 | 3,761 | $3.2M | $580,079 |
| 2020 | 12 | 2,167 | 3,076 | $2.6M | $481,545 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 659 | 1,141 | $2.6M | $398,360 | 15.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 672 | 1,168 | $118,400 | $26,857 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 417 | 435 | $56,985 | $26,715 | 46.9% |
| 66174 | Dilation of fluid outflow drainage within eye | Facility | 2023 | 29 | 47 | $117,500 | $19,294 | 16.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 90 | 106 | $63,600 | $19,271 | 30.3% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 19 | 23 | $51,750 | $11,373 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $23,490 | $8,702 | 37.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 54 | 54 | $14,526 | $5,245 | 36.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 51 | 52 | $11,544 | $4,178 | 36.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 13 | 13 | $7,800 | $3,555 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 30 | $5,220 | $2,320 | 44.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 167 | 168 | $33,400 | $1,892 | 5.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 27 | 27 | $2,241 | $622.34 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 21 | $1,638 | $614.33 | 37.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 11 | 13 | $2,119 | $549.76 | 25.9% |
| 92134 | Imaging of retina | Office | 2023 | 18 | 19 | $1,615 | $500.97 | 31.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 653 | 1,098 | $2.5M | $384,489 | 15.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 126 | 146 | $87,600 | $27,485 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 422 | 447 | $58,511 | $27,464 | 46.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2022 | 663 | 1,136 | $113,700 | $26,252 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 151 | 151 | $40,770 | $15,608 | 38.3% |
| 66174 | Dilation to improve eye fluid flow | Facility | 2022 | 16 | 26 | $65,000 | $14,124 | 21.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 17 | 19 | $42,750 | $8,332 | 19.5% |
| 66986 | Exchange of prosthetic lens | Facility | 2022 | 13 | 14 | $24,500 | $7,764 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 82 | $14,268 | $6,781 | 47.5% |
About Dr. James Loden, M.D
Dr. James Loden, M.D is a Ophthalmology healthcare provider based in Goodlettsville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659330272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Loden, M.D has received a total of $389,755 in payments from pharmaceutical and medical device companies, with $951.69 received in 2024. These payments were reported across 281 transactions from 31 companies. The most common payment nature is "" ($321,507).
As a Medicare-enrolled provider, Loden has provided services to 9,690 Medicare beneficiaries, totaling 13,767 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Goodlettsville, TN
- Active Since 03/22/2006
- Last Updated 11/12/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659330272
Products in Payments
- Tecnis 1-piece IOL (Device) $211,053
- Healon Viscoelastics (Device) $89,992
- Tecnis Symphony IOL (Device) $29,000
- LENSAR LASER SYSTEM (Device) $13,158
- Catalys Laser System (Device) $10,518
- iDesign Advanced Wavescan Studio (Device) $5,400
- STAR S4 IR Excimer Laser system (Device) $5,112
- Tecnis Toric 1-piece IOL (Device) $4,729
- IDESIGN RS (Device) $3,600
- OCULUS Keratograph 5M (Device) $3,000
- Z8 (Device) $2,500
- CLEARVISC (Device) $2,175
- CATALYS SYSTEM (Device) $1,818
- Omidria (Drug) $1,720
- VisuMax (Device) $658.44
- TECNIS IOL (Device) $355.38
- DURYSTA (Drug) $343.41
- Tecnis Simplicity (Device) $326.28
- Ophthalmic Surgical Adjuncts (Device) $225.88
- XIIDRA (Drug) $163.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.